IMNM Immunome
- 13.280
- +0.130+0.99%
- 13.490
- +0.210+1.58%
Immunome News
Evaluating Immunome: Insights From 4 Financial Analysts
In the preceding three months, 4 analysts have released ratings for Immunome (NASDAQ:IMNM), presenting a wide array of perspectives from bullish to bearish.The following table provides a quick overvie
Immunome Initiated at Overweight by Piper Sandler
Immunome Initiated at Overweight by Piper Sandler
Express News | Piper Sandler Initiates Coverage On Immunome With Overweight Rating, Announces Price Target of $27
Immunome Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/31/2024 87.5% Piper Sandler → $27 Initiates Coverage On → Overweight 04/30/2024 66.67% JP Morgan → $24
Bullish Immunome Insiders Loaded Up On US$2.67m Of Stock
Over the last year, a good number of insiders have significantly increased their holdings in Immunome, Inc. (NASDAQ:IMNM). This is encouraging because it indicates that insiders are more optimistic ab
Immunome (NASDAQ:IMNM): An Opportunity for Investors With Strong Stomachs
Immunome(IMNM.US) Director Buys US$27,139.8 in Common Stock
$Immunome(IMNM.US)$ Director BIENAIME JEAN JACQUES purchased 2,000 shares of common stock on May 21, 2024 at an average price of $13.5699 for a total value of $27,139.8.Source: Announcement What is st
Over $13M Bet On ProFrac Holding? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the sto
Immunome(IMNM.US) Officer Buys US$1.39 Million in Common Stock
$Immunome(IMNM.US)$ Officer SIEGALL CLAY B purchased 100K shares of common stock on May 20, 21, 2024 at an average price of $13.8807 for a total value of $1.39 million.Source: Announcement What is sta
Express News | Immunome Shares Are Trading Higher After a Form4 Filing Showed President and CEO Clay Siegall Bought 100,000 Shares at an Average Price of $13.88 per Share
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersRezolute (NASDAQ:RZLT) stock increased by 52.7% to $4.58 during Tuesday's after-market session. The company's market cap stands at $183.8 million. The company's, Q3 earnings came out 4 days ago
Express News | Immunome Form 4 Filing Shows President And CEO Clay B Siegall Bought 100,000 Shares Of Stock At A Price Of $13.88/Share
Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing
Clay B Siegall, Director, President and CEO, on May 20, 2024, executed a purchase for 100,000 shares in Immunome (IMNM) for $1,388,072. Following the Form 4 filing with the SEC, Siegall has control ov
Immunome Announces Completion of Purchase of Assets From Atreca
Immunome, Inc. (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the completion of its purchase of antibodies and related assets
Immunome Appoints CFO
Express News | Immunome Announces Promotion of Max Rosett to Chief Financial Officer
Immunome Announces Promotion Of Max Rosett To Chief Financial Officer >IMNM
Immunome Announces Promotion Of Max Rosett To Chief Financial Officer >IMNM
Immunome's Promising Pipeline and Strategic Positioning Affirm Buy Rating
Immunome, Inc. Q1 Loss Increases, Misses Estimates
Express News | Immunome - Entered Into Sales Agreement With TD Cowen, Relating to Shares of Common Stock Offered by Prospectus Supplement
Analysis
Price Target
No Data
